MarketPeel
Insider Trading Intelligence
RL

Ra Capital Nexus Fund Iv, L.p.

COAG
DIRECTOR · HEMAB THERAPEUTICS HOLDINGS, INC. · CIK 0002053586
FILING MIX · LIFETIME60%/40%
BUYS
9
SELLS
6
TOTAL VALUE
$52.22M
COMPANIES
1
ACTIVE SINCE
May 2026
HOLDINGS NOW
6,261,118
AVG SELL PX
TRADE KIND
SHOWING 15 / 15
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Ra Capital Nexus Fund Iv, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+5.48%+2.04%+3.45%+1.61%
14d3+100.00%+8.10%+3.38%+3.76%+3.76%
30d3+100.00%+8.82%+3.18%+6.10%+6.10%
60d3+100.00%+23.98%+2.71%+21.78%+21.78%
90d3(3 pending)
180d3(3 pending)
1y3(3 pending)
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COAG · 6,261,118 shares · as of May 6, 2026
01,578,6313,157,2634,735,8946,314,525SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 9 buys / 6 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
53,407$24.83$1.33M6,314,525May 6, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
14,611$23.77$347.3K6,261,118May 6, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
10,268$25.00$256.7K6,246,507May 5, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
87,143$24.59$2.14M6,236,239May 5, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
2,541,250$18.00$45.74M6,149,096May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
27,7200May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
64,6800May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
42,3410May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
56,9720May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
18,1460May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
SALE
10,0540May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
3,607,8463,607,846May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
133,750$18.00$2.41M354,938May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
221,188221,188May 4, 2026May 6, 2026View →
COAG
HEMAB THERAPEUTICS HOLDINGS, INC.
PURCHASE
1,009,0521,009,052May 4, 2026May 6, 2026View →
Other insiders · COAG
Loading peer insiders…
About this filer
CIK 0002053586
ROLE
Director
PRIMARY
COAG
COMPANIES
1
ACTIVE SINCE
May 2026
MARKETPEEL · /INSIDER/0002053586DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback